- $7.74m
- $105.08m
- $68.67m
- 29
- 69
- 18
- 33
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.11 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -66.78% | ||
| Return on Equity | n/a | ||
| Operating Margin | -56.91% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 48.1 | 125.73 | 113.29 | 66.8 | 68.67 | 83 | 100.5 | 10.14% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.
Directors
- James Liken NEC (71)
- Joseph Army PRE (57)
- John Landry CFO (48)
- Brian Lawrence SVP (52)
- Gregoire Ramade SVP (51)
- Dorota Mckay CAO (39)
- Lori Knowles DRC
- Mary Moynihan DRC
- Anthony Arnerich IND (71)
- Lance Berry IND (48)
- Donald Spence IND (67)
- Elizabeth Weatherman IND (61)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 12th, 2013
- Public Since
- November 14th, 2018
- No. of Shareholders
- 168
- No. of Employees
- 182
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Pink Sheets on Nasdaq- Shares in Issue
- 6,193,851
- Address
- 100 Domain Drive, EXETER, 03833
- Web
- https://vapotherm.com/
- Phone
- +1 6036580411
- Auditors
- Grant Thornton LLP
Upcoming Events for VAPO
Vapotherm Inc Annual Shareholders Meeting
Q2 2024 Vapotherm Inc Earnings Release
Similar to VAPO
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
Aksys
Pink Sheets on Nasdaq
FAQ
What is the Vapotherm share price?
As of Today at 19:22 UTC, shares in Vapotherm are trading at $1.25. This share price information is delayed by 15 minutes.
How has the Vapotherm share price performed this year?
Shares in Vapotherm last closed at $1.25 and the price had moved by -67.83% over the past 365 days. In terms of relative price strength the Vapotherm share price has underperformed the S&P500 Index by -72.21% over the past year.
What are the analyst and broker recommendations for Vapotherm?
The overall consensus recommendation for Vapotherm is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Vapotherm dividend yield?
Vapotherm does not currently pay a dividend.
Does Vapotherm pay a dividend?
Vapotherm does not currently pay a dividend.
When does Vapotherm next pay dividends?
Vapotherm does not currently pay a dividend.
How do I buy Vapotherm shares?
To buy shares in Vapotherm you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vapotherm?
As of the previous close price of $1.25, shares in Vapotherm had a market capitalisation of $7.74m.
Where are Vapotherm shares listed?
Here are the trading details for Vapotherm:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: VAPO
What kind of share is Vapotherm?
Based on an overall assessment of its quality, value and momentum Vapotherm is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vapotherm share price forecast for 2024?
The analyst consensus target price for shares in Vapotherm is $1.00. That is 20% below the last closing price of $1.25.
Analysts covering Vapotherm currently have a consensus Earnings Per Share (EPS) forecast of -$2.88 for the next financial year.
What is the trend in the Vapotherm share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vapotherm. Over the past six months, its share price has underperformed the S&P500 Index by -62.48%.
As of the last closing price of $1.25, shares in Vapotherm were trading -40.44% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vapotherm PE Ratio?
The Vapotherm PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vapotherm?
Vapotherm's management team is headed by:
- James Liken - NEC
- Joseph Army - PRE
- John Landry - CFO
- Brian Lawrence - SVP
- Gregoire Ramade - SVP
- Dorota Mckay - CAO
- Lori Knowles - DRC
- Mary Moynihan - DRC
- Anthony Arnerich - IND
- Lance Berry - IND
- Donald Spence - IND
- Elizabeth Weatherman - IND